Construction of a Cuproptosis-Related lncRNA Prognostic Model for Bladder Urothelial Carcinoma and Screening of Potential Drugs

Figure 5

Patient risk score in relation to risk and survival and the expression analysis of 11 screened lncRNA in the high and low risk of Train group and Test group. (a) Patient risk score was associated with risk in the Train group. (b) Patient risk score was associated with risk in the Test group. (c) Patient risk score was associated with survival in the Train group. (d) Patient risk score was associated with survival in the Test group. (e) Expression of 11 lncRNA screened in Train group in high- and low-risk groups. (f) Expression of 11 lncRNA screened in Test group in high- and low-risk groups.

(a)

(b)

(c)

(d)

(e)

(f)